157 related articles for article (PubMed ID: 35443293)
1. Molecular classification of endometrial cancer: entering an era of precision medicine.
Goulder A; Gaillard SL
J Gynecol Oncol; 2022 May; 33(3):e47. PubMed ID: 35443293
[No Abstract] [Full Text] [Related]
2. Lumping and splitting: The need for precision medicine and "personomics" in endometrial cancer.
Reyes-Baez FE; Garzon S; Mariani A
J Gynecol Oncol; 2021 Mar; 32(2):e38. PubMed ID: 33650339
[No Abstract] [Full Text] [Related]
3. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Jamieson A; Barroilhet LM; McAlpine JN
Cancer; 2022 Aug; 128(15):2853-2857. PubMed ID: 35657171
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in endometrial cancer.
McAlpine JN; Gilks CB
Gynecol Oncol; 2019 Sep; 154(3):451-453. PubMed ID: 31472758
[No Abstract] [Full Text] [Related]
5. Summary of the 2013 American Association for Cancer Research (AACR) Annual Meeting.
Landen CN; Lengyel E
Gynecol Oncol; 2013 Jul; 130(1):6-8. PubMed ID: 23926600
[No Abstract] [Full Text] [Related]
6. Classification of endometrial carcinoma: more than two types.
Murali R; Soslow RA; Weigelt B
Lancet Oncol; 2014 Jun; 15(7):e268-78. PubMed ID: 24872110
[TBL] [Abstract][Full Text] [Related]
7. Cancer genomics and clinical practice: how can we close the gap more quickly?
Konecny GE
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
[No Abstract] [Full Text] [Related]
8. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options.
MacKay HJ; Freixinos VR; Fleming GF
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32239967
[TBL] [Abstract][Full Text] [Related]
10. Genetic landscape of clear cell endometrial cancer and the era of precision medicine.
Huang GS; Santin AD
Cancer; 2017 Sep; 123(17):3216-3218. PubMed ID: 28485840
[No Abstract] [Full Text] [Related]
11. An miRNA signature associated with tumor mutation burden in endometrial cancer.
Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
[TBL] [Abstract][Full Text] [Related]
12. Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.
Gizzo S; Fabris A; Litta P; Saccardi C
Int J Clin Exp Pathol; 2014; 7(5):2664-9. PubMed ID: 24966983
[TBL] [Abstract][Full Text] [Related]
13. Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Abdulfatah E; Wakeling E; Sakr S; Al-Obaidy K; Bandyopadhyay S; Morris R; Feldman G; Ali-Fehmi R
Gynecol Oncol; 2019 Sep; 154(3):467-474. PubMed ID: 31248668
[TBL] [Abstract][Full Text] [Related]
14. Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.
Collins A; Miles GJ; Powley IR; Hew R; Pringle JH; MacFarlane M; Pritchard C; Moss EL
Gynecol Oncol; 2021 Feb; 160(2):557-567. PubMed ID: 33309417
[TBL] [Abstract][Full Text] [Related]
15. Slow and steady wins the race: precision medicine for low risk endometrial cancer.
Kurnit KC; Westin SN
Int J Gynecol Cancer; 2020 Jun; 30(6):724-725. PubMed ID: 32376741
[No Abstract] [Full Text] [Related]
16. Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma.
Depreeuw J; Stelloo E; Osse EM; Creutzberg CL; Nout RA; Moisse M; Garcia-Dios DA; Dewaele M; Willekens K; Marine JC; Matias-Guiu X; Amant F; Lambrechts D; Bosse T
Clin Cancer Res; 2017 Dec; 23(23):7232-7241. PubMed ID: 28939739
[No Abstract] [Full Text] [Related]
17. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
19. Integration of Clinical and Molecular Features into Prediction Models for Outcomes in Endometrial Cancer.
Miller MD; Devor EJ
Clin Obstet Gynecol; 2020 Mar; 63(1):40-47. PubMed ID: 31725417
[TBL] [Abstract][Full Text] [Related]
20. [Issues and reflections in the era of molecular classification for endometrial cancer].
Yu SN; Zong LJ; Chen J; Lu ZH
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):585-588. PubMed ID: 35785828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
